Impaired stria vascularis in the inner ear of apolipoprotein E gene knockout mice

ORL

Volumn 70, Issue 6, 2008, Pages 373-380

  Zhu, Shanshan ^a   Du, Xiaoping ^a,b   Cai, Qing ^a,b   Guo, Yunkai ^c   Liu, Li ^b   Cheng, Weihua ^b   Tao, Zezhang ^a   Yoo, Taijune ^b,d  

^a RENMIN HOSPITAL OF WUHAN UNIVERSITY   (China)

^b UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^c CENTRAL SOUTH UNIVERSITY   (China)

^d NONE   (United States)

Author keywords

Apoptosis; Gene mutation; Hyperlipidemia; Inner ear; Stria vascularis

Indexed keywords

APOLIPOPROTEIN E; CASPASE 3; ENDOTHELIAL NITRIC OXIDE SYNTHASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CAPILLARY DENSITY; CELL DEATH; CONTROLLED STUDY; GENE MUTATION; HYPERLIPIDEMIA; INNER EAR MALFORMATION; KNOCKOUT GENE; MOUSE; NICK END LABELING; NONHUMAN; PRIORITY JOURNAL; STRIA VASCULARIS;

ANALYSIS OF VARIANCE; ANIMALS; APOLIPOPROTEINS E; APOPTOSIS; CASPASE 3; CELL DEATH; COCHLEA; DISEASE MODELS, ANIMAL; IMMUNOHISTOCHEMISTRY; IN SITU NICK-END LABELING; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NITRIC OXIDE SYNTHASE; ORGAN OF CORTI; PROBABILITY; RANDOM ALLOCATION; REFERENCE VALUES; SPECIES SPECIFICITY; STRIA VASCULARIS;

EID: 55549119627     PISSN: 03011569     EISSN: None     Source Type: Journal    
DOI: 10.1159/000163033     Document Type: Article

References (34)

1. Cunningham DR, Goetzinger CP: Extrahigh frequency hearing loss and hyperlipidemia. Audiology 1974; 13: 470-484.
2. Morizono T, Paparella MM: Hypercholesterolemia and auditory dysfunction, experimental studies. Ann Otol Rhinol Laryngol 1978; 87: 804-814.
3. Morizono T, Sikora MA: Experimental hypercholesterolemia and auditory function in the chinchilla. Otolaryngol Head Neck Surg 1982; 90: 814-818.
4. Axelsson A, Lindgren F: Is there a relationship between hypercholesterolaemia and noise-induced hearing loss. Acta Otolaryngol 1985; 100: 379-386.
5. Pillsbury HC: Hypertension, hyperlipoproteinemia, chronic noise exposure: is there synergism in cochlear pathology? Laryngoscope 1986; 96: 1112-1138.
6. Sikora MA, Morizono T, Ward WD, Paparella MM, Leslie K: Diet-induced hyperlipidemia and auditory dysfunction. Acta Otolaryngol 1986; 102: 372-381.
7. Guo Y, Zhang C, Du X, Nair U, Yoo TJ: Morphological and functional alterations of the cochlea in apolipoprotein E gene deficient mice. Hear Res 2005; 208: 54-67.
8. Plump AS, Smith JD, Hayek T, Aalto-Setala K, Walsh A, Verstuyft JG, Rubin EM, Breslow JL: Severe hypercholesterolemia and atherosclerosis in apolipoprotein E-deficient mice created by homologous recombination in ES cells. Cell 1992; 72: 343-353.
9. Piedrahita JA, Zhang SH, Hagaman JR, Oliver PM, Maeda N: Generation of mice carrying a mutant apolipoprotein E gene inactivated by gene targeting in embryonic stem cells. Proc Natl Acad Sci USA 1992; 89: 4471-4475.
10. Zhang SH, Reddick RL, Piedrahita JA, Maeda N: Spontaneous hypercholesterolemia and arterial lesions in mice lacking apolipoprotein E. Science 1992; 258: 468-471.
11. D'Uscio LV, Smith LA, Katusic ZS: Hypercholesterolemia impairs endothelium-dependent relaxations in common carotid arteries of apolipoprotein E-deficient mice. Stroke 2001; 32: 2658-2664.
12. Getz GS: Mouse model of unstable atherosclerotic plaque? Arterioscler Thromb Vasc Biol 2000; 20: 2503-2505.
13. Nakashima Y, Plump AS, Raines EW, Breslow JL, Ross R: ApoE-deficient mice develop lesions of all phases of atherosclerosis throughout the arterial tree. Arterioscler Thromb Vasc Biol 1994; 14: 133-140.
14. Oemar BS, Tschudi MR, Godoy N, Brovkovich V, Malinski T, Luscher TF: Reduced endothelial nitric oxide synthase expression and production in human atherosclerosis. Circulation 1998; 97: 2494-2498.
15. Rosenfeld ME, Polinsky P, Virmani R, Kauser K, Rubanyi G, Schwartz SM: Advanced atherosclerotic lesions in the innominate artery of the ApoE knockout mouse. Arterioscler Thromb Vasc Biol 2000; 20: 2587-2592.
16. Seo HS, Lombardi DM, Polinsky P, Powell-Braxton L, Bunting S, Schwartz SM, Rosenfeld ME: Peripheral vascular stenosis in apolipoprotein E-deficient mice: potential role of lipid deposition, medial atrophy, and adventitial inflammation. Arterioscler Thromb Vasc Biol 1997; 17: 3593-3601.
17. Fullerton SM, Strittmatter WJ, Matthew WD: Peripheral sensory nerve defects in apolipoprotein E knockout mice. Exp Neurol 1998; 153: 156-163.
18. Masliah E, Mallory M, Ge N, Alford M, Veinbergs I, Roses AD: Neurodegeneration in the central nervous system of ApoE-deficient mice. Exp Neurol 1995; 136: 107-122.
19. Drouet B, Fifre A, Pincon-Raymond M, Vandekerckhove J, Rosseneu M, Gueant JL, Chambaz J, Pillot T: ApoE protects cortical neurons against neurotoxicity induced by the non-fibrillar C-terminal domain of the amyloid-β peptide. J Neurochem 2001; 76: 117-127.
20. Ong JM, Zorapapel NC, Aoki AM, Brown DJ, Nesburn AB, Rich KA, Kenney CM: Impaired electroretinogram (ERG) response in apolipoprotein E-deficient mice. Curr Eye Res 2003; 27: 15-24.
21. Mercer J, Figg N, Stoneman V, Braganza D, Bennett MR: Endogenous p53 protects vascular smooth muscle cells from apoptosis and reduces atherosclerosis in ApoE knockout mice. Circ Res 2005; 96: 667-674.
22. Tanaka K, Sata M, Fukuda D, Suematsu Y, Motomura N, Takamoto S, Hirata Y, Nagai R: Age-associated aortic stenosis in apolipoprotein E-deficient mice. J Am Coll Cardiol 2005; 46: 134-141.
23. Veurink G, Liu D, Taddei K, Perry G, Smith MA, Robertson TA, Hone E, Groth DM, Atwood CS, Martins RN: Reduction of inclusion body pathology in ApoE-deficient mice fed a combination of antioxidants. Free Radic Biol Med 2003; 34: 1070-1077.
24. Grainger DJ, Reckless J, McKilligin E: Apolipoprotein E modulates clearance of apoptotic bodies in vitro and in vivo, resulting in a systemic proinflammatory state in apolipoprotein E-deficient mice. J Immunol 2004; 173: 6366-6375.
25. Fernandes-Alnemri T, Litwack G, Alnemri ES: CPP32, a novel human apoptotic protein with homology to Caenorhabditis elegans cell death protein Ced-3 and mammalian interleukin-1 beta-converting enzyme. J Biol Chem 1994; 269: 30761-30764.
26. Liu X, Li P, Widlak P, Zou H, Luo X, Garrard WT, Wang X: The 40-kDa subunit of DNA fragmentation factor induces DNA fragmentation and chromatin condensation during apoptosis. Proc Natl Acad Sci USA 1998; 95: 8461-8466.
27. Couffinhal T, Silver M, Kearney M, Sullivan A, Witzenbichler B, Magner M, Annex B, Peters K, Isner JM: Impaired collateral vessel development associated with reduced expression of vascular endothelial growth factor in ApoE-/- mice. Circulation 1999; 99: 3188-3198.
28. Gosepath K, Gath I, Maurer J, Pollock JS, Amedee R, Forstermann U, Mann W: Characterization of nitric oxide synthase isoforms expressed in different structures of the guinea pig cochlea. Brain Res 1997; 747: 26-33.
29. Lee JE, Nakagawa T, Kita T, Kim TS, Iguchi F, Endo T, Shiga A, Lee SH, Ito J: Mechanisms of apoptosis induced by cisplatin in marginal cells in mouse stria vascularis. ORL J Otorhinolaryngol Relat Spec 2004; 66: 111-118.
30. Usami S, Takumi Y, Fujita S, Shinkawa H, Hosokawa M: Cell death in the inner ear associated with aging is apoptosis? Brain Res 1997; 747: 147-150.
31. Spieker LE, Luscher TF: Protection of endothelial function. Handb Exp Pharmacol 2005; 170: 619-644.
32. Jiang ZG, Shi X, Zhao H, Si JQ, Nuttall AL: Basal nitric oxide production contributes to membrane potential and vasotone regulation of guinea pig in vitro spiral modiolar artery. Hear Res 2004; 189: 92-100.
33. Van Belle E, Rivard A, Chen D, Silver M, Bunting S, Ferrara N, Symes JF, Bauters C, Isner JM: Hypercholesterolemia attenuates angiogenesis but does not preclude augmentation by angiogenic cytokines. Circulation 1997; 96: 2667-2674.
34. Satar B, Ozkaptan Y, Surucu HS, Ozturk H: Ultrastructural effects of hypercholesterolemia on the cochlea. Otol Neurotol 2001; 22: 786-789.